Long Term Vital Parameter Monitoring (LAVIMO)
LAVIMO
2 other identifiers
interventional
8
1 country
1
Brief Summary
The purpose of this study is to evaluate the feasibility of non-intrusive 24 hours non-invasive measurements with minimized LAVIMO sensor system. The LAVIMO-system is a photoplethysmographic device for reflective mode measurements of the optical damping upper skin layers inside of the ear canal at two different wave lengths. It consists of the in-ear sensor, the electronics and a PC. Vital signs parameter like heart rate, heart rate variability, breathing and arterial blood oxygenation are monitored in patients with sleep apnoea and compared to measurements of standard polysomnography of these patients during one night in the sleep laboratory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 20, 2012
CompletedFirst Posted
Study publicly available on registry
June 22, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedNovember 27, 2013
November 1, 2013
1.1 years
June 20, 2012
November 26, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Extraction of vital signs out of measurement data via individually formed in-ear sensor system in comparison to standard polysomnography data in sleep laboratory
during one polysomnographic night in sleep laboratory the patient will receive the LAVIMO in- ear sensor system and vital parameters like heart rate, heart rate variability, breathing and oxygen saturation will be monitored. Subsequently the data will be processed and compared to the standard polysomnographic data
one night
Study Arms (1)
Device: in-ear sensor
EXPERIMENTALPatients who routinely undergo a polysomnography night (1 night) are monitored via in-ear sensor which will be embedded in the auditory canal. During this night vital signs parameters are monitored, processed and subsequently compared to the polysomnography data.
Interventions
Long term vital signs parameters like heart rate, heart rate variability, breathing and oxygen saturation are measured via in- ear sensor system during 1 polysomnographic night
Eligibility Criteria
You may qualify if:
- patients \> 18 years who routinely have to undergo a polysomnography night
- sleep apnoea patient
- able to give informed consent
You may not qualify if:
- dementia
- cochlea implant
- severe lung diseases
- allergy against material of the sensor
- inflammation of the middle ear
- inflammation of auditory canal
- occlusion because of cerumen
- electric implants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neurological Clinic , University Hospital
Aachen, North Rhine-Westphalia, 52074, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Johannes Schiefer, MD
Neurological Clinic, University Hospital Aachen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2012
First Posted
June 22, 2012
Study Start
January 1, 2012
Primary Completion
February 1, 2013
Study Completion
February 1, 2013
Last Updated
November 27, 2013
Record last verified: 2013-11